Pharmacy Times

JUNE 9, 2025

A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.

Compounding Pharmacies 73

Compounding Pharmacies Hospitals Immunization Chemotherapy 73

PharmTech

JUNE 23, 2025

Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com Performing calculations for the formulation of pharmaceutical dosage forms and related preparations is a key activity in compounding. It builds on drug calculations topics previously described (1), including guidance documents (2–5). Pluta Nishant B. Active moiety.

Compounding 52

Compounding Dosage Labelling FDA 52

Pharmacy Times

JUNE 20, 2025

Other documented causes of secondary dysmenorrhea include fibroids, adenomyosis, infection, myomas, obstructive reproductive tract anomalies, and ovarian cysts About the Author Yvette C. American Pharmaceutical Association; 2025. Accessed April 28, 2025. Accessed April 28, 2025. December 2018. Smith RP, Kaunitz AM.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Immunization Compounding 65

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. During this time frame, the pharmacy documented 152 interventions. Proactive strategies in oncology care enhance financial sustainability and improve patient outcomes. Withholding shipment saved $1.9

Mail-Order Pharmacies 73

Mail-Order Pharmacies Compounding Pharmacies Medical Records Dosage 73

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share what you presented at the 2025 OPC meeting? Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting. Heidi Finnes, PharmD, BCOP, FHOPA : I shared new hope in cutaneous malignancies and abstracts from the 2025 ASCO meeting.

Compounding Pharmacies 65

Compounding Pharmacies Immunization Mayo Clinic Hospitals 65

The Checkup by Singlecare

JUNE 5, 2025

When Zepbound is covered, prior authorization is usually required, and the patient may need to meet clinical requirements such as a BMI of 30 or more or a BMI of 27 or more with a comorbid condition like hypertension or Type 2 diabetes, and documented weight management efforts like a low-calorie diet and increased physical activity.

Insurance 52

Insurance Customer Service Compounding Documentation 52

Pharmacy Times

JULY 2, 2025

They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements. Accessed July 2, 2025. Accessed July 2, 2025. Accessed June, 2025. of participants discontinued due to adverse effects. News release. February 21, 2020.

Compounding Pharmacies 130

Compounding Pharmacies FDA Immunization Specialty Pharmacies 130

Drug Topics

JULY 7, 2025

The study cohort included 136 patients with a confirmed HAE type 1 or 2 diagnosis who had at least 2 documented HAE attacks within 3 months prior to screening. July 7, 2025. Accessed July 7, 2025. Accessed July 7, 2025. 1 The decision makes sebetralstat the first and only oral on demand treatment option for the condition.

FDA 315

FDA Vaccines Specialty Pharmacies Compounding 315

Pharmacy Times

JULY 22, 2025

While the European Medicines Agency mandated pre-treatment DPD testing in Europe as early as 2020, and the UK’s National Health Service followed suit the same year, the US only reached a consensus in 2025. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.

Compounding Pharmacies 50

Compounding Pharmacies FDA Hospitals Immunization 50

Drug Topics

JULY 8, 2025

TCSs are the first-line anti-inflammatory treatment and their effectiveness and safety have been well documented.” Accessed July 8, 2025. The next step consists of treatment with topical anti-inflammatory therapies. 2 To better understand the prominence of corticophobia, researchers evaluated HCPs’ management strategies for AD.

Vaccines 466

Vaccines Specialty Pharmacies Compounding Communication 466

Pharmacy Times

JULY 2, 2025

The CRL was received after OLC’s initial Prescription Drug User Fee Act date of June 28, 2025, and cited for deficiencies that are unrelated to OLC itself. The manufacturer reported that, as part of the NDA review, they have not highlighted any technical concerns related to the submitted documentation or testing of OLC. June 30, 2025.

FDA 73

FDA Compounding Pharmacies Vaccines Immunization 73

Drug Topics

JUNE 11, 2025

This led researchers to explore a specific region of the world in order to better document patients’ understanding of the disease. The prevalence of psoriasis in the Gulf countries is not well-documented; however, recent studies suggested that psoriasis affects 0.5%-5.3% Accessed June 11, 2025. Accessed June 11, 2025.

Immunization 315

Immunization Documentation Specialty Pharmacies Compounding 315

Pharmacy Times

JUNE 22, 2025

Sayer: The most documented, most significant benefits If you take a look at the trials we've run, first of all, you always see an A1c reduction, because average glucose values go down and A1c follows. Even just glucose numbers, that's way more than they've had before.

Compounding Pharmacies 65

Compounding Pharmacies Hospitals Vaccines Immunization 65

Pharmacy Times

JULY 1, 2025

We all share the same electronic health record and document every patient interaction in the health record, and we have very easy access to reach out to the patient's provider to let them know of any questions or concerns that the patient has regarding their medication.

Specialty Pharmacies 65

Specialty Pharmacies Insurance Compounding Pharmacies Hospitals 65

Pharmacy Times

JULY 18, 2025

Rumore, PharmD, Esq, MS, LLM, FAPhA Key Takeaways The removal of tirzepatide and semaglutide from the FDA's shortage list impacts 503A compounders, requiring adherence to complex legal and regulatory frameworks. The definition of "essentially a copy" is pivotal, influencing compounding practices and legal interpretations.

Compounding 73

Compounding Compounding Pharmacies Documentation FDA 73

Pharmacy Times

JULY 17, 2025

Patients were excluded if they had a primary mental health diagnosis of a substance use disorder or no documented Behavioral Health Initial Assessment Form in the electronic medical record. Due to incomplete documentation, the MARS score could not be calculated for all the patients.

HIV Treatment and Prevention Agents 65

HIV Treatment and Prevention Agents Hospitals Compounding Pharmacies Documentation 65

Drug Topics

JUNE 25, 2025

Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.

Vaccines 387

Vaccines Independent Pharmacies Immunization Compounding 387

Pharmaceutical Commerce

JULY 16, 2025

1 In response to this immense demand, coupled with high costs and accessibility issues, compounded alternatives have emerged as a seemingly pragmatic solution. However, these compounded GLP-1s are creating a significant, often underestimated, legal, reputational, and financial minefield for startups and the broader life sciences industry.

Compounding 69

Compounding Insurance FDA Compounding Pharmacies 69

Pharmacy Times

JUNE 23, 2025

That'll all be fully implemented by the end of 2025. We just must do a good job of documenting them and develop that clinical evidence base that supports it. It's time for another compound. People want products reimbursed, and they're much more likely to use a product if it's paid for by the insurance system.

Insurance Coverage 65

Insurance Coverage Compounding Pharmacies Compounding Insurance 65

Pharmacy Times

JULY 9, 2025

2 Evidence Supporting Supplementation A randomized controlled trial involving high-dose vitamin D (300 IU/kg/day, up to 5000 IU/day) in children with ASD documented meaningful improvements in Childhood Autism Rating Scale (CARS) scores, repetitive behaviors, eye contact, and attention after 4 months, without toxicity.

Compounding Pharmacies 100

Compounding Pharmacies Immunization Specialty Pharmacies Compounding 100

PharmTech

JULY 17, 2025

3d render, number six glowing in the dark, pink blue neon light | Image Credit: © NeoLeo - stock.adobe.com Pharmaceutical compounding, particularly in 503A and 503B environments, involves complex formulation and regulatory challenges far beyond academic theory. antineoplastics, allergens). antineoplastics, allergens).

Compounding 59

Compounding Dosage Packaging Labelling 59

Pharmaceutical Technology

JULY 2, 2025

July 2, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Logistics is crucial for successful cell and gene therapy treatments. In addition, documentation of the material is required, along with clearly defined next steps for modification and expansion. Credit: via Shutterstock. Login Registration is disabled.

Packaging 52

Packaging Compounding Communication FDA 52

The Checkup by Singlecare

MARCH 10, 2025

The medication is available in both brand-name and compounded forms, although the compounded forms are not FDA approved. Compounded semaglutide is made by special compounding pharmacies rather than pharmaceutical companies. Does insurance cover compounded semaglutide? affected by a shortage).

Compounding 52

Compounding Insurance Insurance Coverage Compounding Pharmacies 52

The FDA Law Blog

SEPTEMBER 11, 2024

FDA says that highly potent compounds – again, as defined in ICH M7(R2) – pose risks below that limit. We note that the other FDA guidance document on nitrosamines addresses NDSRIs. The revisions due in 2025 include testing for NDSRIs. Using the guidelines found in the ICH M7(R2) , FDA set an AI threshold of 1.5

FDA 105

FDA Documentation Compounding 105

ISPE

NOVEMBER 2, 2022

Strategic plan refresh for 2023–2025 involved an adaptation from the existing strategic plan, with the Society taking a “very confident position: Shaping the Future of Pharma and bringing quality medicines to patients worldwide.”. Expenses for documents and conferences have been higher this year.

Documentation 52

Documentation Compounding Communication FDA 52

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. EMA Regulatory Science to 2025: Strategic Reflection.” 3 , 27 Advantages POD increases manufacturing flexibility, speed, and consistency.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

European Pharmaceutical Review

MAY 8, 2025

The document outlines alternative approaches to animal testing, including Threshold of Toxicological Concern (TTC), Quantitative Structure Activity Relationship (Q)SAR), Read Across Approaches (RAX), and in vitro approaches. Compounds that are poorly degraded or eliminated can increase concerns as they may accumulate over time.

Compounding 52

Compounding Documentation FDA 52

The Thyroid Pharmacist

MAY 12, 2025

In a study done in 2010, NAC and 15-Deoxy-Prostaglandin J2 (a fatty acid compound with antioxidant and anti-inflammatory properties) exerted a protective effect against autoimmune thyroid destruction in vivo. [16] Published 2025 Mar 20. Research has shown that people with Hashimotos have lower levels of glutathione. Reprod Fertil.

Immunization 58

Immunization Documentation Dosage Compounding 58